Step 1 topics → Reproductive → HPV (Condyloma and Cancer)

HPV (Condyloma and Cancer)

USMLE Step 1 trap: Confuses low-risk HPV strains (warts) with high-risk strains (cancer). Low-risk strains (6, 11) cause condyloma acuminata; high-risk strains (16, 18) cause cervical, oropharyngeal, and anogenital cancers.

HPV is one of the most tested STIs on USMLE Step 1, and the exam hits it from two angles: the biology of which strains do what, and the public health logic of vaccination. The core concept is that HPV is not one disease — low-risk strains (6, 11) cause benign condyloma acuminata (genital warts), while high-risk strains (16, 18) drive cervical, oropharyngeal, and anogenital cancers through their oncoproteins. These are distinct strain groups with distinct outcomes, and the exam will exploit any tendency to lump them together.

The mechanistic depth Step 1 wants goes beyond 'HPV causes cancer.' You need to know that E6 degrades p53 and E7 inactivates Rb — two separate tumor suppressors, two separate oncoproteins. This is exactly the kind of paired fact the exam loves to test in a passage-based question where they describe a protein interaction and ask you to identify the downstream consequence. If you only know that 'HPV disrupts tumor suppressors' without knowing which protein targets which, you'll miss the application-level question.

Vaccination is the management angle, and it trips students up because of a common misconception about age cutoffs. The vaccine is most effective before sexual debut, but it's recommended through age 26 routinely and up to age 45 with shared decision-making — not just for teenagers. USMLE Step 1 is likely to present a clinical vignette with an adult patient and ask whether vaccination is appropriate; knowing the extended age range is what separates the correct answer from the tempting wrong one.

From real student decks
8%have cards covering this topic
8%have mature cards
2median lapses in 14 days

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake
Wrong: The HPV strains that cause genital warts (condyloma acuminata) are the same ones that cause cervical cancer.
Right: Low-risk strains (6, 11) cause condyloma acuminata; high-risk strains (16, 18) cause cervical, oropharyngeal, and anogenital cancers.
The strains that cause warts and the strains that cause cancer are biologically distinct groups — low-risk strains (6, 11) lack the oncogenic potential of high-risk strains (16, 18) because their E6/E7 proteins bind tumor suppressors with much lower affinity. A patient with condyloma acuminata does not have elevated cervical cancer risk from those same warts — this is a different strain. On the exam, if a question describes visible genital warts, think 6/11; if it describes dysplasia or carcinoma, think 16/18.
Common mistake
Wrong: The HPV vaccine is only effective if given before age 15.
Right: The HPV vaccine is recommended through age 26 for all individuals and may be given up to age 45 after shared decision-making, but is most effective before sexual debut.
The 'before age 15' cutoff reflects dosing schedule (2-dose series if started before 15, 3-dose if started at 15 or later), not the upper limit of eligibility. The vaccine is routinely recommended through age 26 for all individuals regardless of prior sexual activity, and can be offered up to age 45 after a conversation about individual risk and likely prior exposure. The key principle is that earlier vaccination means higher likelihood of protection before any HPV exposure — but 'not yet exposed to all strains' remains possible even in adulthood.
Common mistake
Wrong: HPV oncoproteins E6 and E7 both target the same tumor suppressor.
Right: HPV E6 degrades p53 and HPV E7 inactivates Rb; together they disable both major tumor suppressor pathways.
E6 and E7 are two separate viral proteins with two separate targets: E6 binds and marks p53 for ubiquitin-mediated degradation (eliminating apoptosis), while E7 binds and inactivates Rb (eliminating cell cycle arrest at G1). Together they knock out both major checkpoints. The exam will isolate one of these interactions and ask about the downstream consequence — for example, 'loss of which pathway' results from E7 expression. If you blur these together, you'll pick the wrong answer even if you know both facts exist.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know which HPV strains cause condyloma acuminata (genital warts) vs. which strains cause cervical and oropharyngeal cancers — the exam tests whether you can correctly assign strains 6/11 to benign warts and strains 16/18 to malignancy without mixing them up.
  2. Know the molecular mechanism of HPV carcinogenesis: E6 degrades p53 and E7 inactivates Rb — the exam tests whether you can identify the correct tumor suppressor target for each oncoprotein, especially in passage-based questions describing a specific protein-protein interaction.
  3. Know the HPV vaccine schedule and the recommended age range — the exam tests whether you understand that the vaccine is indicated through age 26 routinely (and up to 45 with shared decision-making) and that its efficacy is highest before first sexual exposure, not just before age 15.

Can you avoid these mistakes?

A 28-year-old woman presents with soft, flesh-colored cauliflower-like lesions on her labia. Biopsy shows koilocytic changes. Which HPV strains are most likely responsible, and what is her risk of cervical cancer from these specific strains?
A researcher finds that a viral protein binds the E2F transcription factor's regulatory partner, preventing G1 arrest. Which HPV oncoprotein is being described, and what is its cellular target?
A 32-year-old woman with no prior HPV vaccination asks if she can still receive the vaccine. What is your recommendation, and what is the most important factor that determines how effective it will be for her?
A 45-year-old man is diagnosed with oropharyngeal squamous cell carcinoma. HPV testing is positive. Which strains are most likely implicated, and through which molecular mechanism did viral infection promote malignant transformation?

Related topics

HPV and Cervical Dysplasia (CIN) Gonadal Differentiation (SRY, MIS, Testosterone) Müllerian vs Wolffian Duct Derivatives 5α-Reductase Deficiency Complete Androgen Insensitivity Syndrome (CAIS)

See how your Anki deck covers this topic.

Upload your deck for a free audit →